Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
MAR 20
Description Community
About
Featuring perspectives from Dr Melissa Johnson, including the following topics:
  • Role of biomarker testing in optimal selection of first-line therapy for patients with non-small cell lung cancer (NSCLC) (0:00)
  • Efficacy and safety with datopotamab deruxtecan for previously treated NSCLC (15:45)
  • Antitumor activity with and current status of CEACAM5-targeted therapy for relapsed NSCLC (30:24)
  • Evolution of drug development and clinical research (37:56)
  • Key findings with sacituzumab govitecan for NSCLC (41:59)
  • Telisotuzumab vedotin for patients with NSCLC and MET expression (48:44)
  • Recent findings with tumor treating fields for metastatic NSCLC after disease progression on platinum-based therapy (50:49)
  • Other novel antibody-drug conjugates under investigation for NSCLC (55:26)
  • Case: A woman in her mid 50s with recurrent extensive-stage small cell lung cancer who developed pneumonitis on ifinatamab deruxtecan (59:05)
  • Case: A woman in her early 60s with complete response to dose-reduced patritumab deruxtecan (1:00:15)

 

Comments